Tokyo, Oct. 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063269) titled 'Effects of Maslinic Acid Intake on Performance, Fatigue, and Associated Decline in Immune Function During Short-Duration Exercise' on Oct. 19.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Yokohama National University
Condition:
Condition - immunity
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study examines the effects of maslinic acid intake on performance, fatigue, and associated immune function during short-duration, high-intensity exercise.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Ingestion of placebo or maslinic acid (60 mg) on the day of the test
Interventions/Control_2 - Conducting the Wingate test (30-second all-out pedaling)
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male
Key inclusion criteria - Individuals with no relevant medical history: Medical history, injuries, surgeries, etc., within the past five years (excluding common colds, influenza, and COVID-19).
Key exclusion criteria - As the test food (maslinic acid) contains porcine gelatin and olive fruit extract, and the control food (placebo) contains porcine gelatin, individuals with allergies to these ingredients are excluded from the study.
Target Size - 30
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 10 Month 05 Day
Date of IRB - 2026 Year 10 Month 05 Day
Anticipated trial start date - 2026 Year 10 Month 19 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072420
Disclaimer: Curated by HT Syndication.
